Study on the Risk of Allergy-like Reactions After Intra-arterial or Intra-venous Injection of the Marketed X-ray Contrast Medium Iopromid

NCT03622801 · clinicaltrials.gov ↗
COMPLETED
Status
133331
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer